TrialDiabetes, obesity & metabolism2020

Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) in Japanese patients with type 2 diabetes mellitus inadequately controlled on basal insulin and oral antidiabetic drugs: The LixiLan JP-L randomized clinical trial.

Hideaki Kaneto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.